Internal Medicine, Medical Oncology · Sherman, TX
NPI
1376581330
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2800 S Highway 75
Sherman, TX, 75090
Phone (903) 892-9455
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.4M
224,987 services
Medicare patients, 2024
682
Average age 75
Drug cost, 2024
$3.4M
1,814 prescriptions
Company payments, 2025
$21.48
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tammy E Roque was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 27,030 times for 37 patients. In total Tammy E Roque billed 224,987 services in 168 codes, and Medicare paid $3.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-02-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 27,030 | 37 | $0.27 | $7,410 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 19,000 | 30 | $44.68 | $849K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 17,200 | 24 | $0.05 | $933 |
| J9299 Injection, nivolumab, 1 mg | Office | 14,680 | 15 | $24.60 | $361K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 13,950 | 47 | $0.11 | $1,537 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 11,160 | 18 | $39.43 | $440K |
| J1756 Injection, iron sucrose, 1 mg | Office | 10,700 | 29 | $0.17 | $1,818 |
| J9267 Injection, paclitaxel, 1 mg | Office | 7,669 | 18 | $0.08 | $620 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 6,985 | 14 | $2.29 | $16K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 6,665 | 71 | $0.10 | $660 |
| J0897 Injection, denosumab, 1 mg | Office | 5,400 | 26 | $20.53 | $111K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,970 | 96 | $0.09 | $267 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,620 | 13 | $37.04 | $97K |
| J9171 Injection, docetaxel, 1 mg | Office | 2,495 | 13 | $0.69 | $1,710 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,350 | 61 | $0.69 | $928 |
By year: 2022 $2.6M for 231,256 services; 2023 $1.2M for 82,656 services; 2024 $3.4M for 224,987 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,044 | 251 | $8.65 | $9,031 |
| 85025 Blood Count | 1,007 | 259 | $7.60 | $7,657 |
| 80053 Clinical Chemistry | 936 | 261 | $10.34 | $9,679 |
| 82728 Clinical Chemistry | 168 | 74 | $13.36 | $2,244 |
| 83540 Clinical Chemistry | 164 | 74 | $6.34 | $1,040 |
| 83550 Clinical Chemistry | 164 | 74 | $8.57 | $1,405 |
| 85007 Blood Count | 73 | 20 | $3.72 | $272 |
| 85027 Blood Count | 73 | 20 | $6.34 | $463 |
| 83735 Clinical Chemistry | 65 | 19 | $6.57 | $427 |
| 83615 Clinical Chemistry | 61 | 39 | $5.92 | $361 |
Medicare prescription drug claims, 2024
In 2024, the drug Tammy E Roque prescribed most often to Medicare patients was Anastrozole, with 127 prescriptions and refills. In total Tammy E Roque wrote 1,814 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 127 | 300 | 33 | $1,882 |
| Letrozole Generic | 116 | 180 | 19 | $1,495 |
| Acyclovir Generic | 111 | 168 | 21 | $1,196 |
| Gabapentin Generic | 92 | 110 | 23 | $925 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 86 | 86 | 29 | $2,425 |
| Pantoprazole Sodium Generic | 63 | 101 | 19 | $515 |
| Dexamethasone Generic | 62 | 66 | 21 | $772 |
| Ondansetron Hcl Generic | 47 | 47 | 21 | $679 |
| Fentanyl Generic | 46 | 46 | 13 | $5,446 |
| Levothyroxine Sodium Generic | 39 | 79 | Under 11 | $248 |
| Morphine Sulfate Er Morphine Sulfate | 39 | 39 | 13 | $1,877 |
| Olanzapine Generic | 36 | 38 | 17 | $183 |
| Hydroxyurea Generic | 34 | 43 | Under 11 | $630 |
| Warfarin Sodium Generic | 32 | 38 | Under 11 | $162 |
| Megestrol Acetate Generic | 31 | 33 | Under 11 | $2,475 |
Brand drugs: - claims; generic drugs: 1,519 claims; opioid claims: 209.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tammy E Roque $21.48 ($21.48 in general payments such as food, travel and fees) from 2 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $21.48.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $21.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.